MUDr. Tomáš Merta
Instructor, Department of Pediatric Oncology
Correspondence Address:
Černopolní 212/9, 662 63 Brno
Phone: | +420 532 23 4511, 4614 |
---|---|
E‑mail: |
Total number of publications: 10
2024
-
Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients
International journal of cancer, year: 2024, volume: 155, edition: 8, DOI
-
Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome
NPJ PRECISION ONCOLOGY, year: 2024, volume: 8, edition: 1, DOI
2022
-
Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing
JCO PRECISION ONCOLOGY, year: 2022, volume: 6, edition: June 2022, DOI
2021
-
Spindle Cell Hemangioma and Atypically Localized Juxtaglomerular Cell Tumor in a Patient with Hereditary BRIP1 Mutation: A Case Report
Genes, year: 2021, volume: 12, edition: 2, DOI
2020
-
Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?
Cancers, year: 2020, volume: 12, edition: 1, DOI
-
Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside
Frontiers in Oncology, year: 2020, volume: 9, edition: FEB 2020, DOI
2019
-
Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario
Frontiers in Oncology, year: 2019, volume: 9, edition: JUL 17 2019, DOI
-
Molekulárně-genetická charakterizace nádoru a léčbu šitá na míru u dětí se solidními nádory
Year: 2019, type: Conference abstract
2018
-
Molekulární tumor board - personalizovaná medicína v každodenní praxi
Year: 2018, type: Conference abstract
-
Prvotní zkušenost s použitím Dinutuximabu-Beta v léčbě Neuroblastomu vysokého rizika
Year: 2018, type: Conference abstract